Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide and
accounts for more than 90% of primary liver cancer. The advent of immune checkpoint …

Hepatocellular carcinoma (HCC) is a common malignant tumor that affecting many people's
lives globally. The common risk factors for HCC include being overweight and obese. The …

© Annals of Translational Medicine. All rights reserved. Ann Transl Med 2023; 11 (5): 226|
https://dx. doi. org/10.21037/atm-22-6548 the authors observed that lipid accumulation in …

Statins as adjuvants - Document - Gale OneFile: Health and Medicine Use this link to get back
to this page. Copy Skip to Content Library Menu: Google Scholar Discovery Partner English …

Hepatocellular carcinoma (HCC) is a common, treatment‐resistant malignancy with a
complex molecular pathogenesis. Statins are a widely used class of cholesterol‐lowering …

Chronic liver disease (CLD) is a major contributor to global mortality, morbidity, and
healthcare burden. Progress in pharmacotherapeutic for CLD management is lagging given …

Significance: Hepatocellular carcinoma (HCC) is a liver malignancy with high mortality rate,
limited treatment options, and poor prognosis. Sorafenib has been the only systemic …

Simple Summary Hepatocellular carcinoma (HCC) is a huge worldwide healthcare burden.
The incidence of non-viral causes of hepatocellular carcinoma, such as non-alcoholic …

Simple Summary Patients with unresectable hepatocellular carcinoma (HCC), the most
common primary tumor of the liver, have poor prognosis and are increasing worldwide. The …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide,
with nearly one million new cases and deaths every year. Owing to the complex …